Brief: Devyser Diagnostics Q3 EBIT Loss Widens To SEK 8.2 Mln

Devyser Diagnostics AB

10/11/2022 06:39

Nov 10 (Reuters) - Devyser Diagnostics AB  DVYSR.ST :
    * DEVYSER DIAGNOSTICS AB PUBLISHES INTERIM REPORT FOR THE
PERIOD,
JANUARY TO SEPTEMBER 2022
    * Q3 NET SALES AMOUNTED TO SEK 31.2 MILLION (24.3)
    * Q3 GROSS PROFIT TOTALED SEK 26.3 MILLION (19.1),
CORRESPONDING
TO A GROSS MARGIN OF 84.4% (78.5)
    * Q3 OPERATING PROFIT (EBIT) AMOUNTED TO SEK -8.2 MILLION
(-2.5)
    * Q3 PROFIT AFTER TAX TOTALED SEK -8.8 MILLION (-3.6)

Source text for Eikon:  ID:nWkr2bDvV8 
Further company coverage:  DVYSR.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))